145 related articles for article (PubMed ID: 30235480)
1. Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia.
Li G; Wang S; Li N; Liu Y; Feng Q; Zuo X; Li X; Hou Y; Shao L; Ma C; Gao C; Hou M; Peng J
Thromb Haemost; 2018 Oct; 118(10):1752-1764. PubMed ID: 30235480
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.
Beckman JD; Rollins-Raval MA; Raval JS; Park YA; Mazepa M; Ma A
Am J Ther; 2018; 25(2):e270-e272. PubMed ID: 29293474
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture.
Mujtahedi SS; Yigitbilek F; Benavides X; Merzkani MA; Ozdogan E; Abozied O; Moore NA; Park WD; Stegall MD
Transpl Immunol; 2022 Dec; 75():101726. PubMed ID: 36183942
[TBL] [Abstract][Full Text] [Related]
4. Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.
Taddeo A; Khodadadi L; Voigt C; Mumtaz IM; Cheng Q; Moser K; Alexander T; Manz RA; Radbruch A; Hiepe F; Hoyer BF
Arthritis Res Ther; 2015 Mar; 17(1):39. PubMed ID: 25889236
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F
Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A
PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021
[TBL] [Abstract][Full Text] [Related]
7. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.
Chen JF; Yang LH; Chang LX; Feng JJ; Liu JQ
Hematology; 2012 Sep; 17(5):283-90. PubMed ID: 22971534
[TBL] [Abstract][Full Text] [Related]
9. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice.
Cheng Q; Khodadadi L; Taddeo A; Klotsche J; F Hoyer B; Radbruch A; Hiepe F
Eur J Immunol; 2018 Jun; 48(6):1020-1029. PubMed ID: 29427452
[TBL] [Abstract][Full Text] [Related]
10. Novel Murine Model of Immune Thrombocytopaenia through Immunized CD41 Knockout Mice.
Li X; Wang SW; Feng Q; Hou Y; Lu N; Ma CH; Gao CJ; Hou M; Peng J
Thromb Haemost; 2019 Mar; 119(3):377-383. PubMed ID: 30630213
[TBL] [Abstract][Full Text] [Related]
11. Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.
Halliley JL; Tipton CM; Liesveld J; Rosenberg AF; Darce J; Gregoretti IV; Popova L; Kaminiski D; Fucile CF; Albizua I; Kyu S; Chiang KY; Bradley KT; Burack R; Slifka M; Hammarlund E; Wu H; Zhao L; Walsh EE; Falsey AR; Randall TD; Cheung WC; Sanz I; Lee FE
Immunity; 2015 Jul; 43(1):132-45. PubMed ID: 26187412
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of immune-related marker detection in idiopathic thrombocytopenic purpura].
Chen JF; Yang LH; Feng JJ; Chang LX; Liu XE; Lu YJ
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):765-8. PubMed ID: 21092448
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
Beyar-Katz O; Magidey K; Ben-Tsedek N; Alishekevitz D; Timaner M; Miller V; Lindzen M; Yarden Y; Avivi I; Shaked Y
J Pathol; 2016 Jul; 239(3):262-73. PubMed ID: 27037906
[TBL] [Abstract][Full Text] [Related]
14. B cells and antibodies in refractory immune thrombocytopenia.
Roeser A; Lazarus AH; Mahévas M
Br J Haematol; 2023 Oct; 203(1):43-53. PubMed ID: 37002711
[TBL] [Abstract][Full Text] [Related]
15. [Significance of detection of anti-GPIIb/IIIa antibody secreting B cells and platelet-specific antibody in patients with idiopathic thrombocytopenic purpura].
Chen JF; Yang LH; Dong CX; Feng JJ; Liu XE; Lu YJ; Chang LX; Liu JQ
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):603-6. PubMed ID: 21122320
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relations between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura in children].
Wang H; Shen B; Yan W; Hou M; Zhu N; Qi H; Hou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):290-4. PubMed ID: 12170464
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura.
Eskazan AE
Ann Hematol; 2016 Oct; 95(11):1751-6. PubMed ID: 27590601
[TBL] [Abstract][Full Text] [Related]
19. Effect of mycophenolic acid and bortezomib on purified human B cells: an in vitro study of long-term functionally stable MICA-sensitized renal recipients.
Li Zw; Wen Xf; Wang Y; Luo M; Qiu Jx
Exp Clin Transplant; 2013 Dec; 11(6):482-8. PubMed ID: 23745955
[TBL] [Abstract][Full Text] [Related]
20. Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice.
Redfield RR; Lou Y; Rodriguez E; Rostami S; Parsons RF; Noorchashm H; Naji A; Abt PL
Transpl Immunol; 2013 Dec; 29(1-4):11-6. PubMed ID: 24103731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]